APO RESEARCH · REPORT
Medical Cold Plasma
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Product & engineering
Understand the product.
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
Selected research
Market Structure
Global Medical Cold Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.
Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.
The global Medical Cold Plasma market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
Read the full market overview
The US & Canada market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Asia Pacific market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Cold Plasma include Apyx Medical, Terraplasma Medical, Wacker Chemie, Neoplas Tools, ADTEC Plasma Technology, Plasmatreat GmbH, Relyon Plasma GmbH, Cinogy GmbH and Plasma Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Cold Plasma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Cold Plasma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Cold Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Cold Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Cold Plasma Segment by Company
Apyx Medical
Terraplasma Medical
Wacker Chemie
Neoplas Tools
ADTEC Plasma Technology
Plasmatreat GmbH
Relyon Plasma GmbH
Cinogy GmbH
Plasma Bioscience
PlasmaMed
Nova Plasma
Medical Cold Plasma Segment by Type
Microwave Plasma
Radio Frequency Plasma
Direct Current Plasma
Medical Cold Plasma Segment by Application
Sterilization and Disinfection
Coagulation and Hemostasis
Dental Applications
Wound Healing
Dermatology Treatment
Beauty and Skin Care
Tumor Treatment
Transfection and Drug Delivery
Material Surface Modification
Medical Cold Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Cold Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Cold Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Cold Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Cold Plasma market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Cold Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Cold Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Cold Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Microwave Plasma
- Radio Frequency Plasma
- Direct Current Plasma
Applications
- Sterilization and Disinfection
- Coagulation and Hemostasis
- Dental Applications
- Wound Healing
- Dermatology Treatment
- Beauty and Skin Care
- Tumor Treatment
- Transfection and Drug Delivery
- Material Surface Modification
Companies covered
- Apyx Medical
- Terraplasma Medical
- Wacker Chemie
- Neoplas Tools
- ADTEC Plasma Technology
- Plasmatreat GmbH
- Relyon Plasma GmbH
- Cinogy GmbH
- Plasma Bioscience
- PlasmaMed
- Nova Plasma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Cold Plasma Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Cold Plasma Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Cold Plasma Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Cold Plasma Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Cold Plasma Market Dynamics
- 2.1 Medical Cold Plasma Industry Trends
- 2.2 Medical Cold Plasma Industry Drivers
- 2.3 Medical Cold Plasma Industry Opportunities and Challenges
- 2.4 Medical Cold Plasma Industry Restraints
3 Medical Cold Plasma Market by Manufacturers
- 3.1 Global Medical Cold Plasma Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Cold Plasma Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Cold Plasma Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Cold Plasma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Cold Plasma Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Cold Plasma Manufacturers, Product Type & Application
- 3.7 Global Medical Cold Plasma Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Cold Plasma Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Cold Plasma Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Cold Plasma Tier 1, Tier 2, and Tier 3
4 Medical Cold Plasma Market by Type
- 4.1 Medical Cold Plasma Type Introduction
- 4.1.1 Microwave Plasma
- 4.1.2 Radio Frequency Plasma
- 4.1.3 Direct Current Plasma
- 4.2 Global Medical Cold Plasma Sales by Type
- 4.2.1 Global Medical Cold Plasma Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Cold Plasma Sales by Type (2021-2032)
- 4.2.3 Global Medical Cold Plasma Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Cold Plasma Revenue by Type
- 4.3.1 Global Medical Cold Plasma Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Cold Plasma Revenue by Type (2021-2032)
- 4.3.3 Global Medical Cold Plasma Revenue Market Share by Type (2021-2032)
5 Medical Cold Plasma Market by Application
- 5.1 Medical Cold Plasma Application Introduction
- 5.1.1 Sterilization and Disinfection
- 5.1.2 Coagulation and Hemostasis
- 5.1.3 Dental Applications
- 5.1.4 Wound Healing
- 5.1.5 Dermatology Treatment
- 5.1.6 Beauty and Skin Care
- 5.1.7 Tumor Treatment
- 5.1.8 Transfection and Drug Delivery
- 5.1.9 Material Surface Modification
- 5.2 Global Medical Cold Plasma Sales by Application
- 5.2.1 Global Medical Cold Plasma Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Cold Plasma Sales by Application (2021-2032)
- 5.2.3 Global Medical Cold Plasma Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Cold Plasma Revenue by Application
- 5.3.1 Global Medical Cold Plasma Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Cold Plasma Revenue by Application (2021-2032)
- 5.3.3 Global Medical Cold Plasma Revenue Market Share by Application (2021-2032)
6 Global Medical Cold Plasma Sales by Region
- 6.1 Global Medical Cold Plasma Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Cold Plasma Sales by Region (2021-2032)
- 6.2.1 Global Medical Cold Plasma Sales by Region (2021-2026)
- 6.2.2 Global Medical Cold Plasma Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Cold Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Cold Plasma Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Cold Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Cold Plasma Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Cold Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Cold Plasma Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Cold Plasma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Cold Plasma Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Cold Plasma Revenue by Region
- 7.1 Global Medical Cold Plasma Revenue by Region
- 7.1.1 Global Medical Cold Plasma Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Cold Plasma Revenue by Region (2021-2026)
- 7.1.3 Global Medical Cold Plasma Revenue by Region (2027-2032)
- 7.1.4 Global Medical Cold Plasma Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Cold Plasma Revenue (2021-2032)
- 7.2.2 North America Medical Cold Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Cold Plasma Revenue (2021-2032)
- 7.3.2 Europe Medical Cold Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Cold Plasma Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Cold Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Cold Plasma Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Cold Plasma Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Apyx Medical
- 8.1.1 Apyx Medical Company Information
- 8.1.2 Apyx Medical Business Overview
- 8.1.3 Apyx Medical Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Apyx Medical Medical Cold Plasma Product Portfolio
- 8.1.5 Apyx Medical Recent Developments
- 8.2 Terraplasma Medical
- 8.2.1 Terraplasma Medical Company Information
- 8.2.2 Terraplasma Medical Business Overview
- 8.2.3 Terraplasma Medical Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Terraplasma Medical Medical Cold Plasma Product Portfolio
- 8.2.5 Terraplasma Medical Recent Developments
- 8.3 Wacker Chemie
- 8.3.1 Wacker Chemie Company Information
- 8.3.2 Wacker Chemie Business Overview
- 8.3.3 Wacker Chemie Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Wacker Chemie Medical Cold Plasma Product Portfolio
- 8.3.5 Wacker Chemie Recent Developments
- 8.4 Neoplas Tools
- 8.4.1 Neoplas Tools Company Information
- 8.4.2 Neoplas Tools Business Overview
- 8.4.3 Neoplas Tools Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Neoplas Tools Medical Cold Plasma Product Portfolio
- 8.4.5 Neoplas Tools Recent Developments
- 8.5 ADTEC Plasma Technology
- 8.5.1 ADTEC Plasma Technology Company Information
- 8.5.2 ADTEC Plasma Technology Business Overview
- 8.5.3 ADTEC Plasma Technology Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 ADTEC Plasma Technology Medical Cold Plasma Product Portfolio
- 8.5.5 ADTEC Plasma Technology Recent Developments
- 8.6 Plasmatreat GmbH
- 8.6.1 Plasmatreat GmbH Company Information
- 8.6.2 Plasmatreat GmbH Business Overview
- 8.6.3 Plasmatreat GmbH Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Plasmatreat GmbH Medical Cold Plasma Product Portfolio
- 8.6.5 Plasmatreat GmbH Recent Developments
- 8.7 Relyon Plasma GmbH
- 8.7.1 Relyon Plasma GmbH Company Information
- 8.7.2 Relyon Plasma GmbH Business Overview
- 8.7.3 Relyon Plasma GmbH Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Relyon Plasma GmbH Medical Cold Plasma Product Portfolio
- 8.7.5 Relyon Plasma GmbH Recent Developments
- 8.8 Cinogy GmbH
- 8.8.1 Cinogy GmbH Company Information
- 8.8.2 Cinogy GmbH Business Overview
- 8.8.3 Cinogy GmbH Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cinogy GmbH Medical Cold Plasma Product Portfolio
- 8.8.5 Cinogy GmbH Recent Developments
- 8.9 Plasma Bioscience
- 8.9.1 Plasma Bioscience Company Information
- 8.9.2 Plasma Bioscience Business Overview
- 8.9.3 Plasma Bioscience Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Plasma Bioscience Medical Cold Plasma Product Portfolio
- 8.9.5 Plasma Bioscience Recent Developments
- 8.10 PlasmaMed
- 8.10.1 PlasmaMed Company Information
- 8.10.2 PlasmaMed Business Overview
- 8.10.3 PlasmaMed Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 PlasmaMed Medical Cold Plasma Product Portfolio
- 8.10.5 PlasmaMed Recent Developments
- 8.11 Nova Plasma
- 8.11.1 Nova Plasma Company Information
- 8.11.2 Nova Plasma Business Overview
- 8.11.3 Nova Plasma Medical Cold Plasma Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Nova Plasma Medical Cold Plasma Product Portfolio
- 8.11.5 Nova Plasma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Cold Plasma Value Chain Analysis
- 9.1.1 Medical Cold Plasma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Cold Plasma Production Mode & Process
- 9.2 Medical Cold Plasma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Cold Plasma Distributors
- 9.2.3 Medical Cold Plasma Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst